TherapeuticsMD Announces FDA Approval of ANNOVERA™ (Segesterone Acetate/Ethinyl Estradiol Vaginal System) for Birth Control

World News: . []

TherapeuticsMD IncNASDAQTXMD an innovative womens healthcare company today announced that the United States US Food and Drug Administration FDA has approved ANNOVERA segesterone acetateethinyl estra diol va...

More news and information about TherapeuticsMD, Inc.

Published By:

Business Wire: 20:05 GMT Friday 10th August 2018

Published: .

Search for other references to "therapeuticsmd" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us